IBB ETF Forecast & Price Targets
IBB Analyst Ratings
Moderate Buy
210Buy20Hold3Sell
Based on the Wall Street analyst consensus for 233 of IBB’s holdings.
IBB 12 Month Forecast
Average Price Target
$267.81▲(23.07% Upside)Based on Wall Street analyst 12-month price targets for 233 of iShares Biotechnology ETF’s holdings in the last 3 months. The average price target is $267.81 with a high forecast of $340.52 and a low forecast of $189.92. The average price target represents a 23.07% change from the last price of $217.61.
Past 12 Months12 Month ForecastJan2026Oct2026
High$340.52
Average$267.81
Low$189.92
Highest Price TargetHighest$340.52Average Price Target$267.81Lowest Price TargetLowest$189.92
IBB Stocks With Highest Upside Potential
IBB Stocks With Highest Downside Potential
IBB ETF FAQ
What is IBB’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 233 of IBB’s holdings, iShares Biotechnology ETF’s 12-month average price target is $267.81.
What is IBB’s upside potential, based on the analysts’ average price target?
IBB’s average price target of $267.81 represents a 23.07% upside from its last price of $217.61.
Is IBB a Buy, Sell or Hold?
iShares Biotechnology ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 233 of IBB’s holdings: 210 rated Buy, 20 rated Hold and 3 rated Sell.
What is iShares Biotechnology ETF’s price target?
The average price target for iShares Biotechnology ETF is $267.81, based on Wall Street analyst 12-month price targets for 233 of IBB’s holdings, issued in the past 3 months. The highest price target is $340.52 and the lowest is $189.92. The average price target represents a 23.07% increase from the last price of $217.61.
What is IBB’s expense ratio?
IBB’s expense ratio is 0.44%.
How many holdings does IBB have?
IBB holds 237 assets.
How can I buy shares of IBB?
You can buy shares of IBB through a brokerage account. Compare brokers on our Best Online Brokers page.
